Form 4: Cel Sci Corp Insider Buys Shares

Cel Sci Corp reports insider Geert Kersten acquired 5,192 shares of common stock on June 30, 2026.

Summary

• Geert Kersten, Chief Executive Officer and Director of Cel Sci Corp, purchased 5,192 shares of common stock on June 30, 2026.
• The transaction was executed at a price of $1.04 per share.
• Following this transaction, Kersten beneficially owns 216,142 shares of common stock, with 311,547 shares held indirectly as Trustee.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine insider transaction without providing new financial or strategic information.

Positives

• Insider buying can signal confidence from management in the company's future prospects.
• The purchase of 5,192 shares by the CEO indicates a personal investment in the company's stock.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider transactions, particularly purchases by senior management, are closely watched by investors as potential indicators of management's belief in the company's valuation and future performance within the biotechnology and pharmaceutical sector.

Stakeholder Impact

• Shareholders may view this insider purchase positively, interpreting it as a sign of confidence from the CEO.

Key Dates

Keywords

Cel Sci Corp, CVM, Insider Trading, Form 4, Stock Purchase, Beneficial Ownership, CEO, Director